WallStreetZenWallStreetZen

NASDAQ: GHRS
Gh Research PLC Stock Forecast, Predictions & Price Target

Analyst price target for GHRS

Based on 2 analysts offering 12 month price targets for Gh Research PLC.
Min Forecast
$39.00+379.7%
Avg Forecast
$39.50+385.85%
Max Forecast
$40.00+392%

Should I buy or sell GHRS stock?

Based on 2 analysts offering ratings for Gh Research PLC.
Buy
Strong Buy
0 analysts 0%
Buy
2 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their GHRS stock forecasts and price targets.

GHRS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-04
lockedlocked$00.00+00.00%2024-03-01

1 of 1

Forecast return on equity

Is GHRS forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
34.53%

Forecast return on assets

Is GHRS forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

GHRS revenue forecast

What is GHRS's revenue in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
$101.3M
Avg 2 year Forecast
$286.7M

GHRS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
GHRS$8.13$39.50+385.85%Buy
XERS$3.04$4.75+56.25%Strong Buy
AVXL$5.11$40.00+682.78%Buy
TRDA$12.38$21.00+69.63%Buy
PEPG$17.30$23.50+35.84%Buy

Gh Research Stock Forecast FAQ

Is Gh Research Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: GHRS) stock is to Buy GHRS stock.

Out of 2 analysts, 0 (0%) are recommending GHRS as a Strong Buy, 2 (100%) are recommending GHRS as a Buy, 0 (0%) are recommending GHRS as a Hold, 0 (0%) are recommending GHRS as a Sell, and 0 (0%) are recommending GHRS as a Strong Sell.

If you're new to stock investing, here's how to buy Gh Research stock.

What is GHRS's revenue growth forecast for 2027-2028?

(NASDAQ: GHRS) Gh Research's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 45.3%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.84%.

Gh Research's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast GHRS's revenue for 2027 to be $5,269,712,004, with the lowest GHRS revenue forecast at $5,269,712,004, and the highest GHRS revenue forecast at $5,269,712,004.

In 2028, GHRS is forecast to generate $14,914,377,408 in revenue, with the lowest revenue forecast at $14,914,377,408 and the highest revenue forecast at $14,914,377,408.

What is GHRS's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: GHRS) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is GHRS's Price Target?

According to 2 Wall Street analysts that have issued a 1 year GHRS price target, the average GHRS price target is $39.50, with the highest GHRS stock price forecast at $40.00 and the lowest GHRS stock price forecast at $39.00.

On average, Wall Street analysts predict that Gh Research's share price could reach $39.50 by Mar 4, 2025. The average Gh Research stock price prediction forecasts a potential upside of 385.85% from the current GHRS share price of $8.13.

What is GHRS's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: GHRS) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.